We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+305.85%
AUM
$11.4B
AUM Growth
-$318M
Cap. Flow
+$3.49M
Cap. Flow %
0.03%
Top 10 Hldgs %
29.99%
Holding
100
New
2
Increased
15
Reduced
62
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$61.8M
2
GSK icon
GSK
GSK
+$48.1M
3
TECK icon
Teck Resources
TECK
+$21.6M
4
AVNS
Avanos Medical
AVNS
+$6.39M
5
CVE icon
Cenovus Energy
CVE
+$4.92M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$37M
2
TLM
TALISMAN ENERGY INC
TLM
+$12.4M
3
KMB icon
Kimberly-Clark
KMB
+$10.3M
4
TRI icon
Thomson Reuters
TRI
+$8.19M
5
SLF icon
Sun Life Financial
SLF
+$6.7M

Sector Composition

Rank Sector Weight
1 Financials 22.78%
2 Energy 19.58%
3 Communication Services 12.9%
4 Technology 8.07%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TECK icon
26
Teck Resources
TECK
$29.6B
$177M 1.55%
12,934,368
+1,412,840
+12% +$21.6M
DVN icon
27
Devon Energy
DVN
$52.1B
$177M 1.55%
2,891,110
-11,975
-0.4% -$726K
HBM icon
28
Hudbay
HBM
$10.1B
$176M 1.54%
20,215,505
+334,415
+2% +$2.61M
IBM icon
29
IBM
IBM
$211B
$176M 1.54%
1,149,705
+11,547
+1% +$1.84M
JNJ icon
30
Johnson & Johnson
JNJ
$618B
$176M 1.54%
1,685,439
-21,600
-1% -$2.28M
BNS icon
31
Scotiabank
BNS
$107B
$168M 1.47%
3,113,808
+60,517
+2% +$3.41M
CMCSK
32
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$160M 1.4%
2,785,990
-68,592
-2% -$3.95M
BPY
33
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$158M 1.39%
6,947,406
-55,800
-0.8% -$1.26M
KMB icon
34
Kimberly-Clark
KMB
$36.3B
$157M 1.37%
1,360,316
-93,173
-6% -$10.3M
INTC icon
35
Intel
INTC
$455B
$151M 1.32%
4,155,459
-54,675
-1% -$1.9M
BAX icon
36
Baxter International
BAX
$13.5B
$150M 1.31%
3,767,965
-26,235
-0.7% -$1.02M
GT icon
37
Goodyear
GT
$2B
$148M 1.3%
5,185,882
-32,808
-0.6% -$812K
GILD icon
38
Gilead Sciences
GILD
$162B
$147M 1.29%
1,562,500
+597,550
+62% +$61.8M
STT icon
39
State Street
STT
$50.6B
$146M 1.27%
1,856,384
-25,890
-1% -$1.94M
UPS icon
40
United Parcel Service
UPS
$88.6B
$138M 1.2%
1,238,003
-12,200
-1% -$1.29M
DD
41
DELISTED
Du Pont De Nemours E I
DD
$126M 1.1%
1,789,563
-19,612
-1% -$1.31M
PEP icon
42
PepsiCo
PEP
$190B
$125M 1.09%
1,320,324
-37,150
-3% -$3.56M
L icon
43
Loews
L
$23.9B
$122M 1.07%
2,902,685
+12,385
+0.4% +$519K
CVE icon
44
Cenovus Energy
CVE
$55.7B
$119M 1.04%
5,768,280
+213,775
+4% +$4.92M
HES
45
DELISTED
Hess
HES
$115M 1.01%
1,558,000
-8,355
-0.5% -$662K
CAE icon
46
CAE Inc. Common Shares
CAE
$8.3B
$114M 1%
8,777,995
-78,050
-0.9% -$1.01M
DMC
47
Del Monte Corp
DMC
$1.41B
$111M 0.97%
3,296,266
-16,125
-0.5% -$525K
VOD icon
48
Vodafone
VOD
$36.3B
$108M 0.94%
3,150,963
-22,847
-0.7% -$770K
PG icon
49
Procter & Gamble
PG
$336B
$105M 0.92%
1,150,505
-31,975
-3% -$2.81M
FCX icon
50
Freeport-McMoran
FCX
$90B
$83.6M 0.73%
3,580,275
-6,285
-0.2% -$173K
1
2
3 4

Similar funds

NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
EIP
Energy Income Partners Westport, Connecticut $6.22B AUM 18.97% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
CA
Cambridge Associates Boston, Massachusetts $6.27B AUM 14.78% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Letko, Brosseau & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Letko, Brosseau & Associates held 100 positions worth $11.4B, down 2.7% from $11.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 4%. Letko, Brosseau & Associates opened 2 new positions and exited 2, leaving the 100-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Energy and Communication Services.

  • Letko, Brosseau & Associates's largest Q4 2014 buy was Avanos Medical: 162,551 shares worth $7.39M.
  • Letko, Brosseau & Associates added most to Gilead Sciences in Q4 2014, an estimated $61.8M increase.
  • Letko, Brosseau & Associates's biggest Q4 2014 reduction was TALISMAN ENERGY INC, cutting an estimated $12.4M.
  • Letko, Brosseau & Associates fully exited AstraZeneca in Q4 2014, selling an estimated $37M.
  • Letko, Brosseau & Associates's ten largest holdings make up 30% of its $11.4B portfolio in Q4 2014.
  • Letko, Brosseau & Associates opened 2 new positions and closed 2 in Q4 2014.
  • Letko, Brosseau & Associates's portfolio value fell 2.7% quarter-over-quarter to $11.4B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2014, filed 10 Feb 2015.